June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Colombian Ocular Inflammatory Diseases Epidemiology Study (COIDES): Optic Neuritis incidence and sociodemographic characterization 2015-2020
Author Affiliations & Notes
  • Alejandra de-la-Torre
    Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT)., Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
    Ophthalmology Interest Group, Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT), Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
  • Camilo Andrés Rodríguez-Rodríguez
    Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT)., Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
    Ophthalmology Interest Group, Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT), Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
  • Carlos Cifuentes-Gonzalez
    Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT)., Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
  • Germán Mejía-Salgado
    Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT)., Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
    Ophthalmology Interest Group, Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT), Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
  • Juan Manuel Garzón-Dangond
    Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT)., Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
  • Angie Vanessa Verbel - Yaneth
    Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT)., Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
    Ophthalmology Interest Group, Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT), Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
  • Sofia Machado-Galindo
    Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT)., Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
    Ophthalmology Interest Group, Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT), Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
  • Danna Lesley Cruz-Reyes
    Grupo de Investigación Clínica, Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogota, Capital District, Colombia
  • Footnotes
    Commercial Relationships   Alejandra de-la-Torre None; Camilo Andrés Rodríguez-Rodríguez None; Carlos Cifuentes-Gonzalez None; Germán Mejía-Salgado None; Juan Manuel Garzón-Dangond None; Angie Vanessa Verbel - Yaneth None; Sofia Machado-Galindo None; Danna Lesley Cruz-Reyes None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3050. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alejandra de-la-Torre, Camilo Andrés Rodríguez-Rodríguez, Carlos Cifuentes-Gonzalez, Germán Mejía-Salgado, Juan Manuel Garzón-Dangond, Angie Vanessa Verbel - Yaneth, Sofia Machado-Galindo, Danna Lesley Cruz-Reyes; Colombian Ocular Inflammatory Diseases Epidemiology Study (COIDES): Optic Neuritis incidence and sociodemographic characterization 2015-2020. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3050.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Optic neuritis (ON) is caused by several immune-mediated inflammatory diseases that affect optic nerve function. Its frequency has yet to be well described in populations from the southern hemisphere. This study aims to estimate the incidence of ON in Colombia.

Methods : A Population-based study was made using the national database from the Colombian Ministry of Health. The International Classification of Diseases-10 code for ON (H46x; H481; G360) was used to estimate the incidence from 2015 to 2019. In addition, we evaluated the impact of the COVID-19 pandemic lockdown on the epidemiology of the disease during 2020, using the Gaussian Random Markov Field model (conditional autoregressive model). Finally, a standardized morbidity rate (SMR) map was created to assess the country's geographic distribution of ON.

Results : From 2015 to 2019, a total of 2,463 new cases of ON were reported. The overall 5-year incidence rate was 1.56 (95% CI: 1.55-1.56) cases per 100,000 consultations; 66% of the patients were females. The presentation peak in males occurred in the quinquennium of 50 to 55 years of age, 45 to 50 in the case of females. During 2020, consultations were reduced in 0.15 cases per 100,000 consultations (Fig 1). The regions with the highest number of cases on the SMR map and increasing risk of new cases were Bogotá, Antioquia, and Valle del Cauca (Fig 2).

Conclusions : Colombia has a slightly lower incidence of ON than the northern hemisphere countries, which has been reported to be between 3.7-5.36 per 100,000 inhabitants. The absence of face-to-face diagnostic methods during the pandemic lockdown drove fewer reported ON cases during 2020. Further studies on the visual outcomes after lockdowns are required.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×